Investigación

Investigación

Sarepta Acquires Investigational Gene Therapy for LGMD2A

[vc_row][vc_column width=»1/6″][/vc_column][vc_column css_animation=»fadeInUp» width=»2/3″][vc_custom_heading text=»Sarepta Acquires Investigational Gene Therapy for LGMD2A» use_theme_fonts=»yes»][vc_empty_space height=»10px»][vc_column_text]Sarepta Therapeutics has executed an exclusive license agreement

Scroll al inicio